This analysis reveals a clear trend towards combination therapies, especially with immune checkpoint inhibitors and targeted treatments, highlighting the significant potential of TIL to enhance therapeutic outcomes and broaden its scope of application.
← all excerpts
Clinical trial landscape for TIL therapy: emerging insights and future directions in oncology.
1
—
—